These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 319751

  • 1. Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin.
    Goodwin CS, Hill JP.
    Antimicrob Agents Chemother; 1977 Jan; 11(1):26-30. PubMed ID: 319751
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of pH upon the activity of cefoxitin.
    Tobe K, Nishino T, Hirai Y, Nakazawa S.
    J Antibiot (Tokyo); 1977 Dec; 30(12):1123-6. PubMed ID: 23373
    [No Abstract] [Full Text] [Related]

  • 7. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979 Dec; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 8. Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.
    Jackson RT, Thomas FE, Alford RH.
    Antimicrob Agents Chemother; 1977 Jan; 11(1):84-7. PubMed ID: 319753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH, Bentfeld G.
    Fortschr Med; 1978 Aug 10; 96(30):1510-7. PubMed ID: 669547
    [Abstract] [Full Text] [Related]

  • 11. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1976 Jun 10; 9(6):994-9. PubMed ID: 938029
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1979 Dec 10; 2(2):31-40. PubMed ID: 398460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1983 Aug 10; 80(2):182-9. PubMed ID: 6881092
    [Abstract] [Full Text] [Related]

  • 20. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG, Stilwell GA, Turck M.
    Antimicrob Agents Chemother; 1976 Jun 10; 9(6):1019-24. PubMed ID: 820241
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.